prenalterol - CISMeF

Preferred Label : prenalterol;

MeSH definition : A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute CARDIAC FAILURE, postmyocardial infarction low-output syndrome, SHOCK, and reducing ORTHOSTATIC HYPOTENSION in the SHY-RAGER SYNDROME.;

CISMeF synonym : 61260-05-7 (Prenalterol hydrochloride);

MeSH hyponym : A-Ba-C-50,005; KWD-2033; H-133-22; H-80-62; prenalterol hydrochloride; H13322; KWD2033; Hydrochloride, Prenalterol; A Ba C 50,005; ABaC50,005; H8062;

MeSH CAS label : phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-;

MeSH Related Number : prenalterol hydrochloride; 57526-81-5 (Prenalterol); 61260-05-7 (HCl); U6VH18LCQ8;

Registry Number MeSH : 57526-81-5;

Related CAS MeSH : U6VH18LCQ8 (Prenalterol hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Prenalterol;

Codes EINECS : 260-791-5;

Is substance : O;

UNII : M4G34404CX;

InChIKey : ADUKCCWBEDSMEB-NSHDSACASA-N;

Details

Origin ID

D011294;

UMLS CUI

C0033051;

ATC code(s)
- prenalterol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- prenalterol [Substance BNPC]
Currated CISMeF NLP mapping
- Prenalterol [ICD-11 Extension code]
Pharmacological action(s)
- adrenergic agents [MeSH Descriptor]
- adrenergic beta-1 receptor agonists [MeSH Descriptor]
- cardiotonic agents [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
Record concept(s)
- A-Ba-C-50,005 [MeSH concept]
- H-133-22 [MeSH concept]
- H-80-62 [MeSH concept]
- KWD-2033 [MeSH concept]
- prenalterol [MeSH concept]
- prenalterol hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- prenalterol sulfate ester [MeSH Supplementary Concept]
See also inter- (CISMeF)
- (S)-4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenol hydrochloride [Substance BNPC]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Prenalterol [ICD-11 Extension code]
- Prenalterol [NCIt concept]
- prenalterol [ATC Code]
- prenalterol [Substance BNPC]
Validated automatic mappings to BTNT
- Prenalterol Hydrochloride [NCIt concept]
- prenalterol [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients